Core Technology
Cellid Co.,Ltd. leads research of anti-cancer immunotherapies and Vaccines for preventing infectious diseases
Mechanism
Antibody production response
B cells activated by BVAC can recognize the tumor antigen and produce a large quantity of antibodies.
The antibodies then bind to the antigens of the tumor cells and mediate killing of the cells by inducing an antibody-dependent immune response.
Scroll left and right to read.
